// App-Quantinova.ai

AB0633 (2018) : Measuring what matters to lupus patients: translating patient views into novel patient-reported outcomes

Researchers

Presenter

  • S. Cleanthous

Principal Investigators

  • A. Regnault

  • M. Schneider

  • C. Gordon

  • S. Bartlett

  • S. Cano

  • T. Morel

Medical Centers

  • Modus Outcomes, Cambridge, MA

  • Modus Outcomes, Lyon, France

  • Policlinic of Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany

  • University of Birmingham, Birmingham, United Kingdom

  • Montreal University, Montreal, QC, Canada

  • UCB Pharma, Brussels, Belgium

Locations

  • United Kingdom

  • France

  • Germany

  • Canada

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Epratuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT02804763

Sponsors

  • UCB Pharma

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved